Near-Infrared Emission CuInS/ZnS Quantum Dots: All-in-One Theranostic Nanomedicines With Intrinsic Fluorescence/Photoacoustic Imaging for Tumor Phototherapy.

Guoxian Lv,Weisheng Guo,Wei Zhang,Tingbin Zhang,Shuyi Li,Shizhu Chen,Ahmed Shaker Eltahan,Dongliang Wang,Yuqing Wang,Jinchao Zhang,Paul C Wang,Jin Chang,Xing-Jie Liang

DOI: https://doi.org/10.1021/acsnano.6b05419

IF: 17.1

2016-01-01

ACS Nano

Abstract:Many theranostic nanomedicines have been fabricated by packaging imaging and therapeutic moieties together. However, concerns about their potential architecture instability and pharmacokinetic complexity remain major obstacles to their clinical translation. Herein, we demonstrated the use of CuInS/ZnS quantum dots (ZCIS QDs) as "all-in-one" theranostic nanomedicines that possess intrinsic imaging and therapeutic capabilities within a well-defined nanostructure. ZCIS QDs were exploited for the first time for multispectral optical tomography (MSOT) imaging and synergistic PTT/PDT therapy. Due to the intrinsic fluorescence/MSOT imaging ability of the ZCIS QDs, their size-dependent distribution profiles were successfully visualized at tumor sites in vivo. Our results showed that the smaller nanomedicines (ZCIS NMs-25) have longer tumor retention times, higher tumor uptake, and deeper tumor penetration than the larger nanomedicines (ZCIS NMs-80). The ability of ZCIS QDs to mediate photo-induced tumor ablation was also explored. Our results verified that under a single 660 nm laser irradiation, the ZCIS NMs had simultaneous inherent photothermal and photodynamic effects, resulting high therapy efficacy against tumor. In summary, the ZCIS QDs as "all-in-one" versatile nanomedicines allow high therapeutic efficacy as well as noninvasively monitoring tumor site localization profile by imaging techniques, and thus hold great potential as precision theranostic nanomedicines.